Inhibits angiotensin-converting enzyme (ACE) with a Ki of 1.2 uM, targets B1 bradykinin receptors (BDKRB1), and potentiates the smooth muscle contraction elicited by bradykinin. In vivo, induces hyperalgesic effects in living rats after intraplantar injection